Vancouver, British Columbia–(Newsfile Corp. – August 12, 2024) – Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) (“Beyond Medical” or the “Company“) announced today the resignation of Independent Board Director, Dr. Hyder A. Khoja.
“We would like to thank Dr. Khoja for his service on the Board since 2017 and wish him well in his future endeavors,” expressed Kal Malhi, CEO of Beyond Medical Technologies Inc.
The Board will begin a search for a new Independent Director and will notify the market when a replacement has been interviewed and selected.
On behalf of the Board of Directors
“Kal Malhi”
Chief Executive Officer
Email: kal@bullruncapital.ca
https://beyond-md.ca/
Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this news release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/219721
CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…
Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…
Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…
Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…
Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…
Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a…